NeuroMetrix, Inc. (NURO)
NASDAQ: NURO · Real-Time Price · USD
4.340
+0.430 (11.00%)
Nov 20, 2024, 4:00 PM EST - Market closed
NeuroMetrix Employees
NeuroMetrix had 26 employees as of December 31, 2023. The number of employees decreased by 1 or -3.70% compared to the previous year.
Employees
26
Change (1Y)
-1
Growth (1Y)
-3.70%
Revenue / Employee
$144,914
Profits / Employee
-$295,203
Market Cap
8.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
IM Cannabis | 95 |
BiomX | 71 |
Eyenovia | 57 |
RedHill Biopharma | 53 |
Jaguar Health | 49 |
FOXO Technologies | 29 |
Virax Biolabs Group | 17 |
Soligenix | 15 |
NURO News
- 3 months ago - NeuroMetrix Reiterates its Review of Strategic Alternatives - GlobeNewsWire
- 3 months ago - NeuroMetrix, Inc. (NURO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - NeuroMetrix, Inc. Announces Date for Second Quarter 2024 Business Highlights Conference Call - GlobeNewsWire
- 6 months ago - NeuroMetrix Reports Q1 2024 Business Highlights - GlobeNewsWire
- 7 months ago - NeuroMetrix Announces Steps Taken to Enhance Shareholder Value - GlobeNewsWire
- 9 months ago - NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy - GlobeNewsWire
- 9 months ago - NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia - GlobeNewsWire
- 9 months ago - Echo Lake Capital Issues Top Ten List of Reasons Why Shai Gozani, CEO of Neurometrix Inc., Should Be Fired - Accesswire